Ingenuity Technology Licensed by SPRI
News Oct 13, 2005
Ingenuity has announced that Schering-Plough Research Institute has licensed both Ingenuity Pathways Analysis and the Ingenuity Pathways Analysis Integration Module (IPA-IM).
Ingenuity Pathways Analysis 3.0 (IPA) is designed to enable biologists and bioinformaticians to model, analyze, and understand the complex biological systems at the core of all life science research.
Ingenuity claims that, IPA leverages the world largest and highest quality knowledge base of biological networks and powerful algorithms, along with a software interface, to provide researchers with the insights and confidence needed to make better and faster decisions at every step of their research.
With access to the release of Ingenuity Pathways Analysis 3.0, scientists will now be able to integrate their own biological relationships with Ingenuity pathways to create custom networks for particular targets, biomarkers, disease areas, and processes and enable powerful computation and functional analysis.
Researchers will also benefit from Ingenuity Pathways Analysis 3.0's vastly expanded search capabilities and a doubling of the gene and disease content.
Unlike most cells in the rest of our body, the DNA (the genome) in each of our brain cells varies from cell to cell, caused by somatic changes. But much remains unknown, including when these changes arise, their size and locations, and whether they are random or regulated. Now, researchers have developed new techniques allowing the detection of CNVs smaller than one million base pairs.